Comparison two methods of oxytocin use after delivery
Not Applicable
- Conditions
- control of third stage.Third-stage haemorrhage
- Registration Number
- IRCT138812043413N1
- Lead Sponsor
- Kashan University of Medical Sciences, Vice-chancellor for Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
woman with vaginal delivery after 20 week gestation without instrumentation, age between 18 and 40 yrs, singleton pregnancies, parity equal or less than 5, Iranian nationality.
Exclusion criteria: Allergy to oxytocin, Presence of any medical or obstetric diseases (including pregnancy-induced hypertension disorders, hypertention, heart diseases, coagulation disorder), known risk factors for postpartum haemorrhage (including abnormal placentation, uterine fibroids, history of postpartum hemorrhage or uterine atony, polyhydramnious , clinical chorioamnionitis , precipitant labor)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Maternal pulse rate and blood pressure. Timepoint: At the admission time and 1, 5, 10, 20 min after delivery. Method of measurement: Maternal pulse rate per mim and blood pressure left hand by using mercury mannometer in supine position by obstetric and gynecologist resident physician.
- Secondary Outcome Measures
Name Time Method Third stage delivery outcome. Timepoint: Immediately after delivery to half an hour for duration of third stage and placenta retention, an hour after delivery for determination of additional uterotonic agent and Hb at the admission time and 6 hours after delivery. Method of measurement: Maternal pulse rate per mim and blood pressure of left hand by using mercury mannometer in supine position by obstetric and gynecologist resident physician.